p53 typically functions as a transcriptional activator to induce anti-proliferative responses to cellular stresses such as DNA damage, genome instability, hypoxia, or oncogenic signaling and is mutated in at least half of human cancers (for review, see Bieging et al. 2014). The gene discussed is TP53; the disease is cancer.